XML 49 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Revenue from Contracts with Customers (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 25, 2021
Jun. 26, 2020
Jun. 25, 2021
Jun. 26, 2020
Dec. 25, 2020
Dec. 27, 2019
Disaggregation of Revenue [Line Items]            
Revenue Reserves $ 302.2 $ 832.7 $ 302.2 $ 832.7 $ 235.4 $ 337.4
Revenue Reserve Provision     1,102.0 990.0    
Revenue Reserve Payments or Credits     (1,035.2) (1,029.1)    
Capitalized Contract Cost, Gross 26.8   26.8   25.8  
Capitalized Contract Cost, Amortization     2.9 2.7    
Net sales (includes retrospective one-time charge of $534.4 million related to the Medicaid lawsuit for the three and six months ended June 26, 2020) 546.4 166.5 1,104.4 832.3    
Medicaid lawsuit (Note 12)         (641.1)  
Sales [Member]            
Disaggregation of Revenue [Line Items]            
Medicaid lawsuit (Note 12) 0.0 534.4 0.0 534.4 [1] (536.0)  
Operating Expense [Member]            
Disaggregation of Revenue [Line Items]            
Medicaid lawsuit (Note 12) $ 0.0 $ (105.3) $ 0.0 $ (105.3)    
Transferred at Point in Time [Member]            
Disaggregation of Revenue [Line Items]            
Revenue 80.30% 77.70% 78.00% 78.10%    
Transferred over Time [Member]            
Disaggregation of Revenue [Line Items]            
Revenue 19.70% 22.30% 22.00% 21.90%    
Royalty [Member]            
Disaggregation of Revenue [Line Items]            
Net sales (includes retrospective one-time charge of $534.4 million related to the Medicaid lawsuit for the three and six months ended June 26, 2020) $ 19.5 $ 16.3 $ 54.9 $ 31.9    
Rebates and Chargebacks [Member]            
Disaggregation of Revenue [Line Items]            
Revenue Reserves 268.7 795.7 268.7 795.7 196.5 295.8
Revenue Reserve Provision     1,059.3 947.5    
Revenue Reserve Payments or Credits     (987.1) (982.0)    
Rebates and Chargebacks [Member] | Sales [Member]            
Disaggregation of Revenue [Line Items]            
Medicaid lawsuit (Note 12) [1]       (534.4)    
Allowance for Sales Returns [Member]            
Disaggregation of Revenue [Line Items]            
Revenue Reserves 21.5 26.3 21.5 26.3 26.6 28.4
Revenue Reserve Provision     14.4 13.3    
Revenue Reserve Payments or Credits     (19.5) (15.4)    
Medicaid lawsuit (Note 12)       0.0    
Other Sales Deductions [Member]            
Disaggregation of Revenue [Line Items]            
Revenue Reserves $ 12.0 $ 10.7 12.0 10.7 $ 12.3 $ 13.2
Revenue Reserve Provision     28.3 29.2    
Revenue Reserve Payments or Credits     $ (28.6) (31.7)    
Medicaid lawsuit (Note 12)       $ 0.0    
Minimum            
Disaggregation of Revenue [Line Items]            
Royalty Rate Percentage     18.00%      
Maximum            
Disaggregation of Revenue [Line Items]            
Royalty Rate Percentage     26.00%      
[1] Excludes the $105.3 million that is reflected as a component of operating expenses as it represents a pre-acquisition contingency related to the portion of the liability that arose from sales of Acthar Gel prior to the Company's acquisition of Questcor Pharmaceuticals Inc. ("Questcor") in August 2014. See Note 12 for further detail on the status of the Medicaid lawsuit.